Factors associated with a negative outcome of medication-overuse headache: A 3-year follow-up (the 'CARE' protocol)

Cephalalgia

Volumn 33, Issue 7, 2013, Pages 431-443

  Sances, Grazia ^a   Galli, Federica ^a   Ghiotto, Natascia ^a   Allena, Marta ^a   Guaschino, Elena ^a   Frustaci, Alessandra ^b   Nappi, Giuseppe ^a   Tassorelli, Cristina ^a,c  

^a C MONDINO NATIONAL NEUROLOGICAL INSTITUTE   (Italy)

^b IRCCS SAN RAFFAELE PISANA   (Italy)

^c UNIVERSITY OF PAVIA   (Italy)

Author keywords

follow up; Medication overuse headache; personality; prognosis

Indexed keywords

BARBITURIC ACID DERIVATIVE; CAFFEINE; ERGOTAMINE DERIVATIVE; NARCOTIC ANALGESIC AGENT; TRIPTAN DERIVATIVE;

ADDICTION; ADULT; ADVERSE OUTCOME; ARTICLE; CHI SQUARE TEST; CLINICAL TRIAL; COFFEE; DEFENSE MECHANISM; DEPRESSION; DISTRESS SYNDROME; DRUG INDUCED HEADACHE; FEAR; FEMALE; FOLLOW UP; HOSTILITY; HUMAN; HYPOCHONDRIASIS; MAJOR CLINICAL STUDY; MALE; MINNESOTA MULTIPHASIC PERSONALITY INVENTORY; PARANOIA; PERSONALITY TEST; RELAPSE; SOCIAL ATTITUDE;

ADULT; ANALGESICS; FEMALE; FOLLOW-UP STUDIES; HEADACHE DISORDERS, SECONDARY; HUMANS; MALE; MENTAL DISORDERS; MIDDLE AGED; MMPI; PERSONALITY; RISK FACTORS; SUBSTANCE-RELATED DISORDERS; TREATMENT OUTCOME;

EID: 84876244409     PISSN: 03331024     EISSN: 14682982     Source Type: Journal    
DOI: 10.1177/0333102413477737     Document Type: Article

References (49)

1. Katsarava Z, Jensen R. Medication-overuse headache: Where are we now?. Curr Opin Neurology. 2007 ; 20: 326-330
2. The International Classification of Headache Disorders: 2nd edition. Cephalalgia. 2004 ; 24: 1-160
3. Silberstein SD, Olesen J, Bousser MG, et al. and the International Headache Society. The International Classification of Headache Disorders, 2nd edition (ICHD-II)-revision of criteria for 8.2 Medication-overuse headache. Cephalalgia. 2005 ; 25: 460-465
4. Olesen J, Bousser MG, Diener HC, et al. New appendix criteria open for a broader concept of chronic migraine. Cephalalgia. 2006 ; 26: 742-746
5. Evers S, Marziniak M. Clinical features, pathophysiology, and treatment of medication-overuse headache. Lancet Neurol. 2010 ; 9: 391-401
6. Ayzenberg I, Obermann M, Nyhuis P, et al. Central sensitization of the trigeminal and somatic nociceptive systems in medication overuse headache mainly involves cerebral supraspinal structures. Cephalalgia. 2006 ; 26: 1106-1114
7. Cevoli S, Mochi M, Scapoli C, et al. Family history for chronic headache and drug overuse as risk factor for headache chronification. Headache. 2008 ; 48: 412-418
8. Di Lorenzo C, Di Lorenzo G, Sances G, et al. Drug consumption in medication overuse headache is influenced by brain-derived neurotrophic factor Val66Met polimorphism. J Headache Pain. 2009 ; 10: 349-355
9. Srikiatkhachorn A, Anthony M. Serotonin receptor adaptation in patients with analgesic-induced headache. Cephalalgia. 1996 ; 16: 419-422
10. Fumal A, Laureys S, Di Clemente L, et al. Orbitofrontal cortex involvement in chronic analgesic-overuse headache evolving from episodic migraine. Brain. 2006 ; 129: 543-550
11. Cupini LM, De Murtas M, Costa C, et al. Obsessive-compulsive disorder and migraine with medication-overuse headache. Headache. 2009 ; 49: 1005-1013
12. Radat F, Creac'h C, Swendsen JD, et al. Psychiatric comorbidity in the evolution from migraine to medication overuse headache. Cephalalgia. 2005 ; 25: 519-522
13. Lauwerier E, Paemeleire K, Van Damme S, et al. Medication use in patients with migraine and medication-overuse headache: The role of problem solving and attitudes about pain medication. Pain. 2011 ; 152: 1334-1339
14. Galli F, Pozzi G, Frustaci A, et al. Differences in the personality profile of medication overuse headache sufferers and drug addict patients: A controlled study using MMPI-2. Headache. 2011 ; 51: 1212-1227
15. Radat F, Creac'h C, Guegan-Massardier E, et al. Behavioral dependence in patients with medication overuse headache: A cross-sectional study in consulting patients using the DSM-IV criteria. Headache. 2008 ; 48: 1026-1036
16. Fuh JL, Wang SJ, Lu SR, Juang KD. Does medication overuse headache represent a behavior of dependence?. Pain. 2005 ; 119: 49-55
17. Evers S, Gralow B, Bauer B, et al. Sumatriptan and ergotamine overuse and drug-induced headache: A clinicoepidemiologic study. Clin Neuropharmacol. 1999 ; 22: 201-206
18. Limmroth V, Katsarava Z, Fritsche G, et al. Features of medication-overuse headache following overuse of different acute headache drugs. Neurology. 2002 ; 59: 1011-1014
19. Dodick DW, Silberstein SD. How clinicians can detect, prevent and treat medication overuse headache. Cephalalgia. 2008 ; 28: 1209-1217
20. Sances G, Ghiotto N, Loi M, et al. A CARE pathway in medication-overuse headache: The experience of the Headache Centre in Pavia. J Headache Pain. 2005 ; 6: 307-309
21. Rossi P, Di Lorenzo C, Faroni J, et al. Advice alone vs. structured detoxification programmes for medication overuse headache: A prospective, randomized, open-label trial in transformed migraine patients with low medical needs. Cephalalgia. 2006 ; 26: 1097-1105
22. Lake AE. Screening and behavioral management: Medication overuse headache - The complex case. Headache. 2008 ; 48: 26-31
23. Tfelt-Hansen P, Krabbe AA. Ergotamine. Do patients benefit from withdrawal?. Cephalalgia. 1981 ; 1 (1). 29-32
24. Rossi P, Faroni J, Nappi G. Medication overuse headache: Predictors and rates of relapse in migraine patients with low medical needs. Cephalalgia. 2008 ; 28: 1196-1200
25. Boe MG, Salvesen R, Mygland A. Chronic daily headache with medication overuse: Predictors of outcome 1 year after withdrawal therapy. Eur J Neurol. 2009 ; 16: 705-712
26. Sances G, Ghiotto N, Galli F, et al. Risk factors in medication overuse headache: A one-year follow-up study ("Care" II protocol). Cephalalgia. 2010 ; 30: 329-336
27. Zidverc-Trajkovic J, Pakmezovic T, Jovanovic Z, et al. Medication overuse headache: Clinical features predicting treatment outcome at 1-year follow-up. Cephalalgia. 2007 ; 27: 1219-1225
28. Evers S, Marziniak M. Clinical features, pathophysiology, and treatment of medication-overuse headache. Lancet Neurol. 2010 ; 9: 391-401
29. Katsarava Z, Muessig M, Dzagnidze A, et al. Medication overuse headache: Rates and predictors for relapse in a 4-year prospective study. Cephalalgia. 2005 ; 25: 12-15
30. Schnider P, Aull S, Baumgartner C, et al. Long-term outcome of patients with headache and drug abuse after in-patient withdrawal: Five-year follow-up. Cephalalgia. 1996 ; 16: 481-485
31. Hagen K, Albretsen C, Vilming ST, et al. A 4-year follow-up of patients with medication-overuse headache previously included in a randomized multicentre study. J Headache Pain. 2011 ; 12: 315-322
32. Hagen K, Jensen R, Boe MG, Stovner LJ. Medication overuse headache: A critical review of end points in recent follow-up studies. J Headache Pain. 2010 ; 11: 373-377
33. Katsarava Z, Limmroth V, Finke M, et al. Rates and predictors for relapse in medication overuse headache: A 1-year prospective study. Neurology. 2003 ; 27:60: 1682-1683
34. Nappi G, Jensen R, Nappi RE, et al. Diaries and calendars for migraine. A review. Cephalalgia. 2006 ; 26: 905-916
35. Ghiotto N, Sances G, Galli F, et al. Medication-overuse headache and applicability of the ICHD-II diagnostic criteria: One-year follow-up study (CARE I protocol). Cephalalgia. 2009 ; 29: 233-243
36. Mazzi F, Morosini P, De Girolamo G, et al. SCID-I CV: Italian Edition. Florence: O.S. Organizzazioni Speciali, 2000.
37. Diagnostic and Statistical Manual of Mental Disorders, 4th edn. Washington: American Psychiatric Association, 1994.
38. Butcher JN, Dahlstrom WG, Graham JR, et al The Minnesota Multiphasic Personality Inventory-2 (MMPI-2): Manual for administration and scoring. Minneapolis, MN: University of Minnesota Press ; 1989 :
39. Sances G, Galli F, Anastasi S, et al. Medication-overuse headache and personality: A controlled study by means of the MMPI-2. Headache. 2010 ; 50: 198-209
40. Tepper SJ, Tepper DE. Breaking the cycle of medication overuse headache. Cleveland Clinic J Med. 2010 ; 77: 236-242
41. Ferrari MD, Roon KI, Lipton RB, Goadsby PJ. Oral triptans (serotonin 5-HT(1B/1D) agonists) in acute migraine treatment: A meta-analysis of 53 trials. Lancet. 2001 ; 358: 1668-1675
42. Guidetti V, Galli F and Sheftell F. Headache attributed to psychiatric disorders. In: Handbook of clinical neurology. Nappi, Moskovitz (EDS): Elsevier, 2011.
43. Fontanillas N, Colas R, Munoz P, et al. Long-term evolution of chronic daily headache with medication overuse in the general population. Headache. 2010 ; 50: 981-988
44. Hagen K, Linde M, Steiner TJ, et al. Risk factors for medication-overuse headache: An 11-year follow-up study. The Nord-Trondelag Health Studies. Pain. 2011 ; 153 (1). 56-61
45. Suhr B, Evers S, Bauer B, et al. Drug-induced headache: long-term results of stationary versus ambulatory withdrawal therapy. Cephalalgia. 1999 ; 19: 44-49
46. Katsarava Z, Muessig M, Dzagnidze A, et al. Medication overuse headache: rates and predictors for relapse in a 4-year prospective study. Cephalalgia. 2004 ; 25: 12-15
47. Schnider P, Aull S, Baumgartner C, et al. Long-term outcome of patients with headache and drug abuse after inpatient withdrawal: Five-year follow-up. Cephalalgia. 1996 ; 16: 481-485
48. Pini LA, Ciero AFG, Sandrini M. Long-term follow-up of patients treated for chronic headache with analgesic overuse. Cephalalgia. 2001 ; 21: 878-883
49. Hagen K, Jensen R, Boe MG, Stovner LJ. Medication overuse headache: A critical review of end points in recent follow-up studies. J Headache Pain. 2010 ; 11: 373-377